Kanadisches Unternehmen möchte mit im Inland hergestelltem generischem Ozempic hervorstechen

Let’s get a domestic peptide market going.

“Vimy Pharma expects to file its application for generic semaglutide to Health Canada in the coming weeks.

Eight other applications are under review by the federal department.”